Activotec provides innovative custom synthesis services, instrumentation and chemicals for chemical research and development.
Our mission is to establish Activotec as the partner of choice for peptide-based drug discovery.
The Company was formed in December 2002 as a spinout from the University of Southampton, with the support of Southampton University's Enterprise Office, the CEI, and benefiting from its partnership with IP2IPO.
Activotec's core focus is customer service whether it's instrument support, delivery of quality custom synthesis services or chemicals, all critical to the success of your science. Our stock of instrument parts, consumables and chemicals offers a first class commitment to customer support.
Activotec offers scientists a single point of expertise and assistance in research, design, manufacture of new, innovative and practical solutions.
The Company develops and pioneers novel methods for the synthesis of peptides and proteins from their constituent parts, amino acids. Using these synthetic methods as an advanced technological platform, the Company is able to produce a wide range of peptides and proteins to order that are difficult to make via other techniques. Particular expertise focuses on difficult to synthesise sequences, non-natural modifications, and the design and synthesis of highly effective peptide immunogens.
Collaboration
Working with our customers Activotec can develop valuable research and development tools to enable scientists using creative solutions to perform chemistry with ease and efficiency. The Company welcomes collaborative projects with biotechnology and pharmaceutical partners to develop new strategies for peptide and protein synthesis.
Activotec has a highly skilled team of research and production chemists, product specialists and service engineer's with unique experience in serving the scientific community.
Activotec is unique in its level of knowledge of the chemical research and development markets, and offers experienced technical, sales and marketing support. The company sells direct to the end-user community.
